Colorectal cancer is one of the leading causes of cancer death worldwide, but it is also one of the most preventable and treatable types of cancer if detected early. In this article, we'll explain everything you need to know about this disease: how to prevent it, traditional and advanced detection methods, and how advanced technologies like Shield tests and genomic testing can be key to a more accurate and personalized diagnosis.
What is colorectal cancer?
Colorectal cancer originates in the colon or rectum, which are part of the digestive tract. This type of cancer usually begins as an abnormal growth (polyp) on the wall of the colon or rectum. If these polyps are not detected and removed early, they can develop into cancerous tumors.
Risk factors include:
- Family history of colorectal cancer.
- High-fat, low-fiber diets.
- Advanced age (50 years or more).
- Inflammatory bowel diseases, such as ulcerative colitis or Crohn's disease.
The importance of early detection
Colorectal cancer in its early stages may not cause any symptoms, making screening tests essential. Traditional methods like colonoscopy are effective, but not always accessible or comfortable for all patients. This is where diagnostic innovation comes in: non-invasive tests like the Shield test.
The Shield test: a breakthrough in colorectal cancer detection
Recently approved by the FDA, the Shield test uses a blood test to detect fragments of tumor DNA in the body. This non-invasive method allows for:
- Detecting colorectal cancer in early stages.
- Reducing barriers to diagnosis in patients who avoid invasive methods.
- To provide reliable and rapid results that can facilitate medical decision-making.
According to the National Cancer Institute, this type of testing can complement prevention strategies and help reduce colorectal cancer mortality.
How can Zogen's genomic testing help you?
At Zogen, we work with advanced genomic tests that also play a crucial role in colorectal cancer. These tests not only assess whether there is a hereditary component, but also offer unique information that can make all the difference in your treatment.
- Genetic risk assessment: If you have a family history of colorectal cancer, our tests can identify inherited mutations that increase your risk.
- Personalized treatment options: We analyze the genetic characteristics of tumors to identify targeted treatments that best suit your case.
- Recurrence monitoring: We help determine if there is an elevated risk of cancer recurrence, allowing your medical team to take preventative measures.
- Prevention for family members: If a hereditary component is identified, your family members may also be able to benefit from prevention strategies.
When should you consider genomic testing?
We recommend you consider this type of testing if:
- You have been diagnosed with colorectal cancer.
- Do you have a family history of colorectal or other cancers?.
- You want to take a preventative approach to your health.
Colorectal cancer can be prevented and treated more effectively if detected early. Tools like the Shield test and Zogen genomic testing represent a significant shift in how we approach this disease, making detection more accessible, less invasive, and more accurate.
If you or a family member have received a cancer diagnosis, or have a family history of cancer, don't hesitate to contact us. We offer telephone consultations to answer your questions. We're here for you.
Fountain: National Cancer Institute (cancer.gov).
